{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:34:04Z","timestamp":1792802044620,"version":"4.5.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/01.med.0000436191.87727.ec","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T08:42:58Z","timestamp":1382431378000},"page":"547-552","source":"Crossref","is-referenced-by-count":57,"title":["Cystic fibrosis-related bone disease"],"prefix":"10.1097","volume":"20","author":[{"given":"Michael S.","family":"Stalvey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Clines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20211004","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1067\/mpd.2002.120269","article-title":"Cystic fibrosis: a 2002 update.","volume":"140","author":"Orenstein","year":"2002","journal-title":"J Pediatr"},{"key":"R3-8-20211004","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archpedi.1979.02130060072016","article-title":"Demineralization in cystic fibrosis detected by direct photon absorptiometry.","volume":"133","author":"Mischler","year":"1979","journal-title":"Am J Dis Child"},{"key":"R4-8-20211004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-128-3-199802010-00004","article-title":"Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis.","volume":"128","author":"Aris","year":"1998","journal-title":"Ann Intern Med"},{"key":"R5-8-20211004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jpeds.2005.04.015","article-title":"Mild to moderate cystic fibrosis is not associated with increased fracture risk in children and adolescents.","volume":"147","author":"Rovner","year":"2005","journal-title":"J Pediatr"},{"key":"R6-8-20211004","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/thx.2005.041236","article-title":"Sternal fracture with fatal outcome in cystic fibrosis.","volume":"60","author":"Latzin","year":"2005","journal-title":"Thorax"},{"key":"R7-8-20211004","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1210\/jc.2004-1629","article-title":"Guide to bone health and disease in cystic fibrosis.","volume":"90","author":"Aris","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-8-20211004","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jcb.22284","article-title":"Endocrine parameters of cystic fibrosis: back to basics.","volume":"108","author":"Stalvey","year":"2009","journal-title":"J Cell Biochem"},{"key":"R9-8-20211004","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1183\/09031936.04.00050204","article-title":"Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor.","volume":"25","author":"King","year":"2005","journal-title":"Eur Respir J"},{"key":"R10-8-20211004","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/01.mcp.0000245708.59138.a4","article-title":"Update on maintaining bone health in cystic fibrosis.","volume":"12","author":"Boyle","year":"2006","journal-title":"Curr Opin Pulm Med"},{"key":"R11-8-20211004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcf.2011.10.004","article-title":"Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents and young adults with cystic fibrosis.","volume":"11","author":"De Schepper","year":"2012","journal-title":"J Cyst Fibros"},{"key":"R12-8-20211004","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1378\/chest.118.2.434","article-title":"Bone histomorphometry in adult patients with cystic fibrosis.","volume":"118","author":"Haworth","year":"2000","journal-title":"Chest"},{"key":"R13-8-20211004","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s001980200007","article-title":"Abnormal bone turnover in cystic fibrosis adults.","volume":"13","author":"Aris","year":"2002","journal-title":"Osteoporos Int"},{"key":"R14-8-20211004","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s001980050202","article-title":"Altered calcium homeostasis in adults with cystic fibrosis.","volume":"10","author":"Aris","year":"1999","journal-title":"Osteoporos Int"},{"key":"R15-8-20211004","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"R16-8-20211004","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1172\/JCI2865","article-title":"Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells.","volume":"101","author":"DiMango","year":"1998","journal-title":"J Clin Invest"},{"key":"R18-8-20211004","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/thx.2003.012047","article-title":"Inflammatory related changes in bone mineral content in adults with cystic fibrosis.","volume":"59","author":"Haworth","year":"2004","journal-title":"Thorax"},{"key":"R19-8-20211004","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1164\/rccm.200512-1943OC","article-title":"Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis.","volume":"174","author":"Shead","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-8-20211004","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc10-1279","article-title":"Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"key":"R21-8-20211004","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/en.2006-1006","article-title":"Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice.","volume":"148","author":"Botolin","year":"2007","journal-title":"Endocrinology"},{"key":"R22-8-20211004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1464-5491.2008.02608.x","article-title":"Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.","volume":"26","author":"Hamilton","year":"2009","journal-title":"Diabet Med"},{"key":"R23-8-20211004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00223-008-9195-5","article-title":"Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes.","volume":"84","author":"Vestergaard","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"R24-8-20211004","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2265.2012.04484.x","article-title":"The impact of dysglycaemia on bone mineral accrual in young people with cystic fibrosis.","volume":"78","author":"Rana","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R25-8-20211004","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/eje.0.1400315","article-title":"Normal spontaneous and stimulated GH levels despite decreased IGF-I concentrations in cystic fibrosis patients.","volume":"140","author":"Laursen","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"R26-8-20211004","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1203\/01.pdr.0000196720.25938.be","article-title":"Mouse as a model of growth retardation in cystic fibrosis.","volume":"59","author":"Rosenberg","year":"2006","journal-title":"Pediatr Res"},{"key":"R27-8-20211004","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00198-005-0058-x","article-title":"Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.","volume":"17","author":"Gordon","year":"2006","journal-title":"Osteoporos Int"},{"key":"R28-8-20211004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2265.1987.tb00776.x","article-title":"Amenorrhoea in cystic fibrosis.","volume":"26","author":"Stead","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R29-8-20211004","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/eje.0.1480551","article-title":"Sex steroids and body composition in men with cystic fibrosis.","volume":"148","author":"Leifke","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"R30-8-20211004","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bone.2004.05.009","article-title":"Prevalence and correlates of vertebral fractures in adults with cystic fibrosis.","volume":"35","author":"Rossini","year":"2004","journal-title":"Bone"},{"key":"R31-8-20211004","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bone.2004.05.021","article-title":"Severe osteopenia in CFTR-null mice.","volume":"35","author":"Dif","year":"2004","journal-title":"Bone"},{"key":"R32-8-20211004","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.200705-659OC","article-title":"Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice.","volume":"177","author":"Haston","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R33-8-20211004","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1203\/PDR.0b013e3181961e80","article-title":"Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.","volume":"65","author":"Pashuck","year":"2009","journal-title":"Pediatr Res"},{"key":"R34-8-20211004","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.ajpath.2012.01.039","article-title":"The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation.","volume":"180","author":"Le Henaff","year":"2012","journal-title":"Am J Pathol"},{"key":"R35-8-20211004","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.257.5073.1083","article-title":"An animal model for cystic fibrosis made by gene targeting.","volume":"257","author":"Snouwaert","year":"1992","journal-title":"Science"},{"key":"R37-8-20211004","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/thx.2006.075887","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone.","volume":"62","author":"Shead","year":"2007","journal-title":"Thorax"},{"key":"R39-8-20211004","first-page":"CD007298","article-title":"Vitamin D supplementation for cystic fibrosis.","volume":"4","author":"Ferguson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R40-8-20211004","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1210\/jc.2011-3050","article-title":"An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation.","volume":"97","author":"Tangpricha","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-8-20211004","first-page":"CD002010","article-title":"Bisphosphonates for osteoporosis in people with cystic fibrosis.","volume":"4","author":"Conwell","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R42-8-20211004","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"R43-8-20211004","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/JPEM.2005.18.6.589","article-title":"Growth hormone improves bone mineral content in children with cystic fibrosis.","volume":"18","author":"Hardin","year":"2005","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["Current Opinion in Endocrinology, Diabetes &amp; Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01266029-201312000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T07:20:21Z","timestamp":1633504821000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01266029-201312000-00008"}},"subtitle":["insights into a growing problem"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/01.med.0000436191.87727.ec","relation":{},"ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}